Literature DB >> 3990165

The effects of a combination of cigarette smoking and oral contraception on coagulation and fibrinolysis in human females.

J Harenberg, C Staiger, J X de Vries, E Weber, R Zimmermann, G Schettler.   

Abstract

Oral contraception as well as cigarette smoking influence haemostasis. The simultaneous effect of both on blood coagulation and fibrinolysis was studied in nine female smokers. While continuing oral contraception after a 4-week abstinence from smoking the concentration of fibrinogen, antithrombin III and alpha 1-Antitrypsin decreased (P less than 0.01 or P less than 0.04) and of plasminogen increased (P less than 0.03). The other coagulation parameters remained unchanged. Although all determinations of these parameters were in the normal range, the observed trends were statistically significant. The concentrations of the fibrinopeptide A and B 15-42 did not differ. It is concluded that the observed alteration is caused by cessation from cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3990165     DOI: 10.1007/bf01731173

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  Myocardial infarction in young women with special reference to oral contraceptive practice.

Authors:  J I Mann; M P Vessey; M Thorogood; S R Doll
Journal:  Br Med J       Date:  1975-05-03

2.  [The intraindividual variation of fibrinolytic activity in volunteers (author's transl)].

Authors:  J Harenberg; E Walter; E Weber
Journal:  Klin Wochenschr       Date:  1978-05-01

3.  Fibrinopeptide A immunoreactivity in human plasma.

Authors:  W B Gerrits; O T Flier; J van der Meer
Journal:  Thromb Res       Date:  1974-08       Impact factor: 3.944

4.  Fibrinopeptide A in human plasma--evaluation of a new radioimmunoassay technique on microliter--plates.

Authors:  J Harenberg; G Hepp; H Schmidt-Gayk
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

5.  Report of the ad hoc committee on cigarette smoking and cardiovascular diseases for health professionals.

Authors:  W B Kannel; J T Doyle; D T Fredrickson; W R Harlan
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

6.  Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.

Authors:  S Sagar; J D Stamatakis; D P Thomas; V V Kakkar
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

7.  Measurement in human blood of fibrinogen/fibrin fragments containing the B beta 15-42 sequence.

Authors:  B Kudryk; D Robinson; C Netré; B Hessel; M Blombäck; B Blombäck
Journal:  Thromb Res       Date:  1982-02-01       Impact factor: 3.944

8.  Gas-liquid chromatographic determination of nicotine and cotinine in plasma.

Authors:  N Hengen; M Hengen
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

9.  Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.

Authors:  H L Nossel; J Wasser; K L Kaplan; K S LaGamma; I Yudelman; R E Canfield
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

10.  Measurement of desarginine fibrinopeptide B in human blood.

Authors:  T Eckhardt; H L Nossel; A Hurlet-Jensen; K S La Gamma; J Owen; M Auerbach
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more
  2 in total

1.  Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers.

Authors:  K Racké; H Schwörer; G Simson
Journal:  Clin Investig       Date:  1992 Mar-Apr

2.  [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct].

Authors:  C Baumgartner; K Huber; F Holzner; K Zeiler; E Auff; B R Binder
Journal:  Klin Wochenschr       Date:  1988-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.